Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/19/2003EP1292186A1 Animal and cell models for type ii diabetes and their use
03/19/2003EP1116727B1 Peptide derivative
03/19/2003EP1082344B1 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/19/2003EP1034268A4 G-protein coupled receptors and uses therefor
03/19/2003EP0957935B1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and method of preparation thereof
03/19/2003EP0910409A4 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
03/19/2003EP0877632B1 Process of preparation of an autologous fibrin glue
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0865609B1 Method of diagnosing and treating epithelioma
03/19/2003EP0846169B1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES
03/19/2003EP0839157B1 Colostrum derived growth factor
03/19/2003EP0804467B1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen
03/19/2003EP0796106B1 Protracted glp-1 compositions
03/19/2003EP0783695B1 Cell tests and diagnostic kit for alzheimer's disease
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003EP0733645B1 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome
03/19/2003EP0722463B1 Methods and composition for the modulation of host immune response to allergens
03/19/2003EP0677104B1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
03/19/2003EP0667902B1 Cdr grafted humanised chimeric t-cell antibodies
03/19/2003EP0595935B1 Papillomavirus Vaccine
03/19/2003EP0556333B1 Avirulent salmonella microbes comprising a mutation in the cdt gene and uses therefor
03/19/2003EP0522138B1 Influenza virus vaccine composition and containing influenza virus core as an additive having a synergistic effect
03/19/2003EP0463101B2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
03/19/2003CN1404488A NOGO receptor-mediated blockade of axonal growth
03/19/2003CN1404486A Purified LH (Luteinizing hormone)
03/19/2003CN1404485A Process of purification of hCG and recombinant hCG purified by that method
03/19/2003CN1404401A G-CSF conjugates
03/19/2003CN1404396A Polypeptoid pulmonary surfactants
03/19/2003CN1403577A Fusion protein of type IV collagenase resistant single chain antibody and Lidamycin agon protein
03/19/2003CN1403483A Human erythropoietin Fc fusion protein with raised bioactivity
03/19/2003CN1403481A Production process of neurotrophic factor
03/19/2003CN1403480A Human protein with function of suppressing cancer cell growth and its coding sequence
03/19/2003CN1403479A Human protein with function of suppressing cancer cell growth and its coding sequence
03/19/2003CN1403478A Human protein with function of suppressing cancer cell growth and its coding sequence
03/19/2003CN1403477A Human protein with function of promoting 3T3 cell conversion and its coding sequence
03/19/2003CN1403476A Human protein with function of promoting 3T3 cell conversion and its coding sequence
03/19/2003CN1403475A Human protein with cancer suppressing function and its coding sequence
03/19/2003CN1403155A Recombinant gamma-interferon for preventing and treating cow's recessive mammitis
03/18/2003US6534695 Identification and characterization of a Dwarf and Late Flowering 2 phenotype (DLF2) in Arabidopsis
03/18/2003US6534645 Compositions and methods enabling a totally internally controlled amplification reaction
03/18/2003US6534644 Isolated polynucleotide of given sequence; use to control lepidopterans and create plants that are insect resistant
03/18/2003US6534642 Isolated nucleic acid of given sequence encoding a protein; dysfunction of the human protein implicated in hyper/hypocalcemia, bone disorders, leukemia and cancer
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534640 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids
03/18/2003US6534638 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/18/2003US6534635 Tissue inhibitors of metalloproteinase (TIMP); electron-accepting group causes it to lose its ability to bind to metalloproteinase; carbamylation; inhibition of metastasis of cancer or vascularization
03/18/2003US6534634 Diagnostic agent and method to determine pregnancy in ruminants
03/18/2003US6534633 Polyspecific binding molecules and uses thereof
03/18/2003US6534631 Of given amino acid sequence; use in diagnosing and treating diseases related to them
03/18/2003US6534630 Connective tissue growth factor-2
03/18/2003US6534629 Isolated protein inhibiting blood coagulation factor X; use in drugs
03/18/2003US6534628 Proteins comprising one or more mutations of surface-exposed amino acids, directing them to different binding partners; stabililty
03/18/2003US6534626 Chemokine variants
03/18/2003US6534485 Novel human protein called Bone Marrow-Specific Protein (BMSP), and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein.
03/18/2003US6534482 Expression vectors for stimulating an immune response and methods of using the same
03/18/2003US6534479 Recombinant alpha-fetoprotein hybrid cytotoxins for treating and diagnosing cancers
03/18/2003US6534477 Production and use of modified cystatins
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534314 Methods and compositions for transforming cells
03/18/2003US6534312 Vaccines comprising synthetic genes
03/18/2003US6534309 Motor proteins and methods for their use
03/18/2003US6534291 Compositions and methods for fumonisin detoxification
03/18/2003US6534290 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
03/18/2003US6534289 Recombinant nucleic acid encoding receptor having amino acid sequences of extracellular domain of G-protein coupled calcium receptor, seven-transmembrane and intracellular cytoplasmic tail domains of group I metabotropic glutamate receptor
03/18/2003US6534288 Precursor of human insulin or insulin analog consisting of optional fusion portion, B chain of human insulin linked by amino acid chain to A chain of human insulin, in which chains can be modified with activity being preserved
03/18/2003US6534287 Isolated and purified nucleic acid molecule comprising nucleotides which code for specified amino acid sequence
03/18/2003US6534286 Protein production in Aureobasidium pullulans
03/18/2003US6534285 Composition comprising predetermined polypeptide sequence of AIDS-associated retrovirus comprising at least one antigenic determinant that specifically binds complementary antibody
03/18/2003US6534276 Methods for detecting human tissue factor inhibitor
03/18/2003US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof
03/18/2003US6534268 Isolated nucleic acid corresponding to specified nucleotide sequence that encodes human bone morphogenetic protein-7 promoter region
03/18/2003US6534267 Polynucleotides encoding activators of caspases
03/18/2003US6534265 Oryzacystatin-I protease inhibitor peptide comprising specified amino acid sequence; insecticides, viricides
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534166 Bioriented polyethylene film with a high water vapor transmission rate
03/18/2003US6534067 Rotavirus enterotoxin adjuvant
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534055 Methods for selectively stimulating proliferation of T cells
03/18/2003US6534051 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
03/18/2003US6534036 Biological materials and methods useful in the diagnosis and treatment of diseases
03/18/2003US6534035 Methods of inhibiting clot formation
03/18/2003CA2263181C Anti-chlamydial methods and materials
03/18/2003CA2220347C Compositions and methods for detecting and treating acquired immunodeficiency syndrome
03/18/2003CA2180261C Peptide sequence that forms mucin sugar chain and technique for modifying protein to be linked with mucin sugar chain
03/18/2003CA2165694C Erythropoietin analogs
03/18/2003CA2139652C Thrombin-inhibitors
03/18/2003CA2126356C Human serum-albumin, preparation and use thereof
03/18/2003CA2121370C Specific tolerance in transplantation
03/18/2003CA2104022C High sulfur seed protein gene and method for increasing the sulfur amino acid content of plants
03/18/2003CA2092519C Synthetic polypeptides as inhibitors of hiv-1
03/18/2003CA2085134C Gdf-1
03/18/2003CA2045175C Production of proteins using homologous recombination
03/18/2003CA2040412C Brain derived neurotrophic factor
03/18/2003CA2005016C Dna fragment containing promoter region for human polypeptide chain elongation factor-1.alpha. and expression plasmid containing the dna fragment
03/18/2003CA1341425C Antibodies to angiogenin: immunotherapeutic agents
03/17/2003WO2002022833A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2422759A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2403157A1 Dna encoding the baboon and cynomolgus macaque prostaglandin e2 receptor ep4 subtype
03/17/2003CA2403058A1 Dna encoding the chimpanzee prostaglandin e2 receptor ep4 subtype
1 ... 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 ... 2916